Neutra
Corp (OTCMKTS:NTRR) has announced the termination of reverse stock
split amid achieving tremendous progress in 2019 toward reaching the long term
goals. To become a vertically integrated firm to compete in the cannabidiol
market, it will concentrate on the acquisition for which discussions are
underway.

Shareholders
to benefit

Sydney Jim, Chief Executive Officer of
Neutra, said the company hired the services of a well-known physician to help
in entering the medicine and sports nutrition markets. Neutra has recently
completed the takeover of VIVIS Corp, a respected and prominent retail firm.
VIVIS is gearing up to unveil hemp-based and transdermal sports cream aimed at
athletes and others looking for immediate relief after engaging in performances
and tough workouts.

Jim said the company is benefiting
from the services of a dedicated sports medicine advisor, who is hired in early
2019. It aims to develop CBD products, which are derived from hemp, to meet the
demand of the growing sports market. The upcoming transdermal cream from VIVIS
would help Americans, who are eagerly waiting to get relief from pain and aches,
and boost their performance, and get protection from injuries. It helps
Americans to lead a healthy lifestyle. Neutra will subject the transdermal
cream of VIVIS to third-party verification to ensure that it is free from
contaminants and maintains potency and consistency.

Several acquisitions now in the
offing, and thanks to the tremendous progress achieved so far in 2019, Neutra
terminated the reverse stock split for the benefit of shareholders and the
company.

Sales
of CBD supplements and remedies

The
sales of supplements and medications that comprise CBD as the key ingredient
are estimated at $51.2 million, an increase of 332.8% in 2018 when compared to
2017. According to industry watchers, the market for CBD would reach $11
billion by the year 2026.

Cannabidiol
(CBD), which is derived from hemp, offers a lot of wellness and health
benefits. According to the user testaments, CBD helps to reduce pain and slows
down neurodegenerative disorders. It also helps to reduce the effects of
seizures and the side effects of specific cancer treatments. CBD is legal and
has no psychoactive effect.

By Steven Russell

Steve covers business and investing in emerging medical marijuana markets. Steve graduated from the university of New Orleans with a degree in Broadcast Journalism. Steve has published several articles in professional journals and magazines. His experience gives readers an inside look at the intersection of his specialties, business and medical marijuana.